Daniel Martin
Corporate Officer/Principal chez DECIPHERA PHARMACEUTICALS, INC.
Fortune : 867 006 $ au 31/03/2024
Profil
Daniel C.
Martin is currently the Chief Commercial Officer & Senior Vice President at Deciphera Pharmaceuticals, Inc. Prior to this, he worked as the Vice President-Marketing & Market Access at Heron Therapeutics, Inc. from 2017 to 2018.
Mr. Martin completed his undergraduate degree at the University of Virginia and earned an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/02/2024 | 55 118 ( 0,07% ) | 867 006 $ | 31/03/2024 |
Postes actifs de Daniel Martin
| Sociétés | Poste | Début |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 18/09/2018 |
Anciens postes connus de Daniel Martin
| Sociétés | Poste | Fin |
|---|---|---|
| HERON THERAPEUTICS, INC. | Sales & Marketing | 01/09/2018 |
Formation de Daniel Martin
| University of Virginia | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
